In silico CD4+ T-cell epitope prediction and HLA distribution analysis for the potential proteins of Neisseria meningitidis Serogroup B—A clue for vaccine development

Neisseria meningitidis, an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries. Three meningococcal serogroup B proteins, i.e. T-cell stimulating protein A (TspA), autotransporter A (AutA), and IgA-specific serine endopeptid...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 28; no. 43; pp. 7092 - 7097
Main Authors Gupta, Shishir K., Smita, Suchi, Sarangi, Aditya Narayan, Srivastava, Mugdha, Akhoon, Bashir A., Rahman, Qamar, Gupta, Shailendra K.
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Ltd 08.10.2010
Elsevier
Elsevier Limited
Subjects
Online AccessGet full text
ISSN0264-410X
1873-2518
1873-2518
DOI10.1016/j.vaccine.2010.08.005

Cover

Abstract Neisseria meningitidis, an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries. Three meningococcal serogroup B proteins, i.e. T-cell stimulating protein A (TspA), autotransporter A (AutA), and IgA-specific serine endopeptidase (IGA1) elicits CD4+ T-cell response and may enhance the effectiveness of meningococcal vaccines by acting as protective immunogens. A very limited data on T-helper cell epitopes in MenB proteins is available. Hence, in silico prediction of peptide sequences which may act as helper T lymphocyte epitopes in MenB proteins was carried out by NetMHCIIpan web server. HLA distribution analysis was done by using the population coverage tool of Immune Epitope Database to determine the fraction of individuals in various populations expected to respond to a given set of predicted T-cell epitopes based on HLA genotype frequencies. Six epitopic core sequences, two from each MenB proteins, i.e. AutA, TspA and IgA1 protease were predicted to associate with a large number of HLA-DR alleles. These six peptides may act as T-cell epitope in more than 95% of populations in 8 out of 12 populations considered. The T-cell stimulation potential of these predicted peptides containing the core epitopic sequences is to be validated by using laboratory experiments for their efficient use as peptide vaccine candidates against N. meningitidis serogroup B.
AbstractList Neisseria meningitidis, an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries. Three meningococcal serogroup B proteins, i.e. T-cell stimulating protein A (TspA), autotransporter A (AutA), and IgA-specific serine endopeptidase (IGA1) elicits CD4+ T-cell response and may enhance the effectiveness of meningococcal vaccines by acting as protective immunogens. A very limited data on T-helper cell epitopes in MenB proteins is available. Hence, in silico prediction of peptide sequences which may act as helper T lymphocyte epitopes in MenB proteins was carried out by NetMHCIIpan web server. HLA distribution analysis was done by using the population coverage tool of Immune Epitope Database to determine the fraction of individuals in various populations expected to respond to a given set of predicted T-cell epitopes based on HLA genotype frequencies. Six epitopic core sequences, two from each MenB proteins, i.e. AutA, TspA and IgA1 protease were predicted to associate with a large number of HLA-DR alleles. These six peptides may act as T-cell epitope in more than 95% of populations in 8 out of 12 populations considered. The T-cell stimulation potential of these predicted peptides containing the core epitopic sequences is to be validated by using laboratory experiments for their efficient use as peptide vaccine candidates against N. meningitidis serogroup B.
Neisseria meningitidis, an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries. Three meningococcal serogroup B proteins, i.e. T-cell stimulating protein A (TspA), autotransporter A (AutA), and IgA-specific serine endopeptidase (IGA1) elicits CD4+ T-cell response and may enhance the effectiveness of meningococcal vaccines by acting as protective immunogens. A very limited data on T-helper cell epitopes inMenBproteins is available. Hence,in silicoprediction of peptide sequences which may act as helper T lymphocyte epitopes inMenBproteins was carried out by NetMHCIIpan web server. HLA distribution analysis was done by using the population coverage tool of Immune Epitope Database to determine the fraction of individuals in various populations expected to respond to a given set of predicted T-cell epitopes based on HLA genotype frequencies. Six epitopic core sequences, two from eachMenBproteins, i.e. AutA, TspA and IgA1 protease were predicted to associate with a large number of HLA-DR alleles. These six peptides may act as T-cell epitope in more than 95% of populations in 8 out of 12 populations considered. The T-cell stimulation potential of these predicted peptides containing the core epitopic sequences is to be validated by using laboratory experiments for their efficient use as peptide vaccine candidates againstN. meningitidisserogroup B.
Abstract Neisseria meningitidis , an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries. Three meningococcal serogroup B proteins, i.e. T-cell stimulating protein A (TspA), autotransporter A (AutA), and IgA-specific serine endopeptidase (IGA1) elicits CD4+ T-cell response and may enhance the effectiveness of meningococcal vaccines by acting as protective immunogens. A very limited data on T-helper cell epitopes in MenB proteins is available. Hence, in silico prediction of peptide sequences which may act as helper T lymphocyte epitopes in MenB proteins was carried out by NetMHCIIpan web server. HLA distribution analysis was done by using the population coverage tool of Immune Epitope Database to determine the fraction of individuals in various populations expected to respond to a given set of predicted T-cell epitopes based on HLA genotype frequencies. Six epitopic core sequences, two from each MenB proteins, i.e. AutA, TspA and IgA1 protease were predicted to associate with a large number of HLA-DR alleles. These six peptides may act as T-cell epitope in more than 95% of populations in 8 out of 12 populations considered. The T-cell stimulation potential of these predicted peptides containing the core epitopic sequences is to be validated by using laboratory experiments for their efficient use as peptide vaccine candidates against N. meningitidis serogroup B.
Neisseria meningitidis, an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries. Three meningococcal serogroup B proteins, i.e. T-cell stimulating protein A (TspA), autotransporter A (AutA), and IgA-specific serine endopeptidase (IGA1) elicits CD4+ T-cell response and may enhance the effectiveness of meningococcal vaccines by acting as protective immunogens. A very limited data on T-helper cell epitopes in MenB proteins is available. Hence, in silico prediction of peptide sequences which may act as helper T lymphocyte epitopes in MenB proteins was carried out by NetMHCIIpan web server. HLA distribution analysis was done by using the population coverage tool of Immune Epitope Database to determine the fraction of individuals in various populations expected to respond to a given set of predicted T-cell epitopes based on HLA genotype frequencies. Six epitopic core sequences, two from each MenB proteins, i.e. AutA, TspA and IgA1 protease were predicted to associate with a large number of HLA-DR alleles. These six peptides may act as T-cell epitope in more than 95% of populations in 8 out of 12 populations considered. The T-cell stimulation potential of these predicted peptides containing the core epitopic sequences is to be validated by using laboratory experiments for their efficient use as peptide vaccine candidates against N. meningitidis serogroup B.Neisseria meningitidis, an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries. Three meningococcal serogroup B proteins, i.e. T-cell stimulating protein A (TspA), autotransporter A (AutA), and IgA-specific serine endopeptidase (IGA1) elicits CD4+ T-cell response and may enhance the effectiveness of meningococcal vaccines by acting as protective immunogens. A very limited data on T-helper cell epitopes in MenB proteins is available. Hence, in silico prediction of peptide sequences which may act as helper T lymphocyte epitopes in MenB proteins was carried out by NetMHCIIpan web server. HLA distribution analysis was done by using the population coverage tool of Immune Epitope Database to determine the fraction of individuals in various populations expected to respond to a given set of predicted T-cell epitopes based on HLA genotype frequencies. Six epitopic core sequences, two from each MenB proteins, i.e. AutA, TspA and IgA1 protease were predicted to associate with a large number of HLA-DR alleles. These six peptides may act as T-cell epitope in more than 95% of populations in 8 out of 12 populations considered. The T-cell stimulation potential of these predicted peptides containing the core epitopic sequences is to be validated by using laboratory experiments for their efficient use as peptide vaccine candidates against N. meningitidis serogroup B.
Neisseria meningitidis, an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries. Three meningococcal serogroup B proteins, i.e. T-cell stimulating protein A (TspA), autotransporter A (AutA), and IgA-specific serine endopeptidase (IGA1) elicits CD4+ T-cell response and may enhance the effectiveness of meningococcal vaccines by acting as protective immunogens. A very limited data on T-helper cell epitopes in MenB proteins is available. Hence, in silico prediction of peptide sequences which may act as helper T lymphocyte epitopes in MenB proteins was carried out by NetMHCIIpan web server. HLA distribution analysis was done by using the population coverage tool of Immune Epitope Database to determine the fraction of individuals in various populations expected to respond to a given set of predicted T-cell epitopes based on HLA genotype frequencies. Six epitopic core sequences, two from each MenB proteins, i.e. AutA, TspA and IgA1 protease were predicted to associate with a large number of HLA-DR alleles. These six peptides may act as T-cell epitope in more than 95% of populations in 8 out of 12 populations considered. The T-cell stimulation potential of these predicted peptides containing the core epitopic sequences is to be validated by using laboratory experiments for their efficient use as peptide vaccine candidates against N. meningitidis serogroup B.
, an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries. Three meningococcal serogroup B proteins, i.e. T-cell stimulating protein A (TspA), autotransporter A (AutA), and IgA-specific serine endopeptidase (IGA1) elicits CD4+ T-cell response and may enhance the effectiveness of meningococcal vaccines by acting as protective immunogens. A very limited data on T-helper cell epitopes in proteins is available. Hence, prediction of peptide sequences which may act as helper T lymphocyte epitopes in proteins was carried out by NetMHCIIpan web server. HLA distribution analysis was done by using the population coverage tool of Immune Epitope Database to determine the fraction of individuals in various populations expected to respond to a given set of predicted T-cell epitopes based on HLA genotype frequencies. Six epitopic core sequences, two from each proteins, i.e. AutA, TspA and IgA1 protease were predicted to associate with a large number of HLA-DR alleles. These six peptides may act as T-cell epitope in more than 95% of populations in 8 out of 12 populations considered. The T-cell stimulation potential of these predicted peptides containing the core epitopic sequences is to be validated by using laboratory experiments for their efficient use as peptide vaccine candidates against serogroup B.
Author Smita, Suchi
Akhoon, Bashir A.
Gupta, Shishir K.
Srivastava, Mugdha
Sarangi, Aditya Narayan
Rahman, Qamar
Gupta, Shailendra K.
Author_xml – sequence: 1
  givenname: Shishir K.
  surname: Gupta
  fullname: Gupta, Shishir K.
  organization: Society for Biological Research & Rural Development, Lucknow, UP, India
– sequence: 2
  givenname: Suchi
  surname: Smita
  fullname: Smita, Suchi
  organization: Department of Bioinformatics, Integral University, Lucknow, UP, India
– sequence: 3
  givenname: Aditya Narayan
  surname: Sarangi
  fullname: Sarangi, Aditya Narayan
  organization: Biomedical Informatics Centre, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, India
– sequence: 4
  givenname: Mugdha
  surname: Srivastava
  fullname: Srivastava, Mugdha
  organization: Society for Biological Research & Rural Development, Lucknow, UP, India
– sequence: 5
  givenname: Bashir A.
  surname: Akhoon
  fullname: Akhoon, Bashir A.
  organization: Centre of Bioinformatics, Department of Biotechnology, SMVD University, Jammu, India
– sequence: 6
  givenname: Qamar
  surname: Rahman
  fullname: Rahman, Qamar
  organization: Department of Bioinformatics, Integral University, Lucknow, UP, India
– sequence: 7
  givenname: Shailendra K.
  surname: Gupta
  fullname: Gupta, Shailendra K.
  email: skgupta@iitr.res.in
  organization: Indian Institute of Toxicology Research (CSIR), P.O. Box 80, MG Marg, Lucknow 226001, India
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23341470$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/20716448$$D View this record in MEDLINE/PubMed
BookMark eNqNku2K1DAUhousuLOjl6AERBSkY9KmH4OojOPHLgz6Y1fYfyFNT9cz20lqki7MPy_Ci_C6vBJTp7owoCsEGk6f9yXnnPcoOtBGQxTdZ3TGKMufrWdXUinUMEtoqNFyRml2K5qwskjjJGPlQTShSc5jzuj5YXTk3JoGImXzO9FhQguWc15Oou8nmjhsURmyfMOfkrNYQdsS6NCbDkhnoUbl0WgidU2OVwtSo_MWq34synbr0JHGWOI_B4HxoD3KNkjDFbUjpiEfAJ0Di5JsQKO-QI_BhpyCNRfW9B15_ePrtwVRbQ-_nMbWSA1X0JouiPzd6HYjWwf3xu80-vTu7dnyOF59fH-yXKxileXcx5Viw8kUrWhCkzLPsjwJTRcMZDNPc1WosqkrJcuUAzRhQDwUG1rxnIbfWTqNHu98w_u_9OC82KAbZiI1mN6JIit4nhYlC-STf5Iso7QokmAb0Id76Nr0NswuUHxeJEme52WgHoxUX22gFp3FjbRb8XtbAXg0AtIp2TZWaoXumktTznhBA5ftOGWNcxaaPwijYkiPWItxxGJIj6ClGLIxjZ7v6RR6OSzaW4ntjepXOzWE9VwhWOEUglYhQRaUF7XBGx1e7jmoFjWGVi9hC-56ZsIlgorTId9DvBmljDF-Hgxe_N3gPx7wE9gDDoE
CODEN VACCDE
CitedBy_id crossref_primary_10_3390_vaccines12121355
crossref_primary_10_1016_j_vaccine_2012_10_091
crossref_primary_10_1016_j_jksus_2021_101751
crossref_primary_10_1016_j_meegid_2012_03_023
crossref_primary_10_1080_21645515_2017_1356961
crossref_primary_10_1016_j_meegid_2010_10_013
crossref_primary_10_1007_s10989_018_9764_z
crossref_primary_10_1186_s12865_015_0119_7
crossref_primary_10_1007_s12010_014_1245_z
crossref_primary_10_1007_s11033_018_4505_0
crossref_primary_10_1016_j_jtbi_2015_08_003
crossref_primary_10_1093_bib_bbv046
crossref_primary_10_1186_1471_2164_14_S6_S4
crossref_primary_10_1016_j_micpath_2011_01_011
crossref_primary_10_1099_mic_0_071829_0
crossref_primary_10_1155_2015_189153
crossref_primary_10_1007_s13205_015_0352_z
crossref_primary_10_1134_S1068162018010193
crossref_primary_10_1007_s13721_016_0142_5
crossref_primary_10_1134_S106816202104021X
crossref_primary_10_1021_pr200806s
crossref_primary_10_1371_journal_pone_0149638
crossref_primary_10_1007_s10989_015_9461_0
crossref_primary_10_1093_femspd_ftv026
crossref_primary_10_1158_2326_6066_CIR_16_0240_T
crossref_primary_10_1007_s00726_010_0830_x
crossref_primary_10_1016_j_meegid_2012_02_022
crossref_primary_10_1016_j_meegid_2021_104795
crossref_primary_10_3389_fmed_2022_1008527
crossref_primary_10_1007_s10517_018_4260_1
Cites_doi 10.1016/S0959-440X(99)00039-1
10.1016/S1359-6446(05)03720-7
10.1128/CMR.2.Suppl.S134
10.1111/j.1399-0039.2008.01083.x
10.1016/j.vaccine.2006.09.032
10.1016/0091-6749(91)92157-V
10.1136/jcp.56.6.417
10.1128/MMBR.57.1.34-49.1993
10.1517/14622416.5.4.417
10.1016/S0022-2836(03)00750-2
10.1016/0264-410X(95)00101-6
10.1016/j.ymeth.2004.06.007
10.1016/j.clim.2008.12.003
10.1016/0264-410X(92)90005-5
10.1016/j.vaccine.2005.01.059
10.1016/S0969-2126(00)00026-5
10.1002/psc.896
10.1586/14760584.4.3.407
10.1517/14622416.5.6.597
10.1007/s002510050594
10.1016/0882-4010(87)90059-3
10.1046/j.1365-2958.2000.02061.x
10.1016/S0167-7012(01)00290-1
10.1016/j.vaccine.2006.03.013
10.1172/JCI109383
10.1016/S0264-410X(01)00283-3
10.1016/0140-6736(91)91961-S
10.1371/journal.pcbi.1000107
10.1093/nar/gkp1004
10.1016/j.it.2003.10.006
10.1016/j.vaccine.2003.10.027
10.1093/infdis/167.5.1065
10.1136/adc.2006.111500
10.1006/mpat.1993.1070
10.1016/j.vaccine.2006.12.023
10.1016/j.vaccine.2004.08.046
10.1007/s002510050595
10.1086/315158
10.1128/IAI.67.7.3533-3541.1999
10.4049/jimmunol.138.12.4402
10.1046/j.1440-1711.2002.01092.x
10.1093/infdis/126.5.514
10.1016/j.vaccine.2007.08.044
10.1186/1471-2105-9-S12-S22
10.1016/j.drudis.2007.03.010
10.1016/S0891-5520(05)70273-7
10.1016/j.vaccine.2006.06.019
10.1016/S0264-410X(02)00407-3
10.1186/1471-2105-7-153
10.1016/j.vaccine.2005.08.111
10.1016/j.vaccine.2009.09.095
10.1186/1756-0500-2-61
10.1016/S0140-6736(83)90340-9
10.1128/IAI.70.1.335-344.2002
ContentType Journal Article
Copyright 2010 Elsevier Ltd
Elsevier Ltd
2015 INIST-CNRS
Copyright © 2010 Elsevier Ltd. All rights reserved.
Copyright Elsevier Limited Oct 8, 2010
Copyright_xml – notice: 2010 Elsevier Ltd
– notice: Elsevier Ltd
– notice: 2015 INIST-CNRS
– notice: Copyright © 2010 Elsevier Ltd. All rights reserved.
– notice: Copyright Elsevier Limited Oct 8, 2010
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7RV
7T2
7T5
7U9
7X7
7XB
88C
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
H94
HCIFZ
K9-
K9.
KB0
LK8
M0R
M0S
M0T
M1P
M2O
M7N
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
DOI 10.1016/j.vaccine.2010.08.005
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Nursing & Allied Health Database
Health and Safety Science Abstracts (Full archive)
Immunology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Healthcare Administration Database (Alumni)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
AIDS and Cancer Research Abstracts
SciTech Premium Collection
Consumer Health Database (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Consumer Health Database
Health & Medical Collection (Alumni)
Healthcare Administration Database
Medical Database
Research Library
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Health Management (Alumni Edition)
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Research Library
Health & Safety Science Abstracts
ProQuest Public Health
ProQuest Central Basic
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
Research Library Prep

MEDLINE - Academic

AIDS and Cancer Research Abstracts

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Veterinary Medicine
Biology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-2518
EndPage 7097
ExternalDocumentID 3216315331
20716448
23341470
10_1016_j_vaccine_2010_08_005
S0264410X1001114X
1_s2_0_S0264410X1001114X
Genre Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
29Q
4.4
457
4G.
53G
5RE
5VS
7-5
71M
7RV
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8P~
9JM
AAAJQ
AABNK
AAEDT
AAEDW
AAHBH
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABJNI
ABKYH
ABMAC
ABMZM
ABRWV
ABUWG
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACLOT
ACMHX
ACPRK
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADMUD
ADNMO
ADSLC
ADVLN
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEUYN
AEVXI
AEXOQ
AFJKZ
AFKRA
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGEKW
AGGSO
AGHFR
AGQPQ
AGUBO
AGWPP
AGYEJ
AHHHB
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AQUVI
ASPBG
AVWKF
AXJTR
AZFZN
AZQEC
BBNVY
BENPR
BHPHI
BKEYQ
BKNYI
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
CCPQU
CJTIS
CNWQP
CS3
DWQXO
EBS
EFJIC
EFKBS
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
FYUFA
G-2
G-Q
GBLVA
GNUQQ
GUQSH
HCIFZ
HEJ
HLV
HMCUK
HMG
HMK
HMO
HVGLF
HX~
HZ~
IHE
J1W
K9-
KOM
L7B
LK8
LUGTX
LW9
M0R
M0T
M1P
M29
M2O
M41
M7P
MO0
N9A
NAPCQ
O-L
O9-
O9~
OAUVE
OK0
OZT
P-8
P-9
P2P
PC.
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
Q38
R2-
ROL
RPZ
SAB
SAE
SCC
SDF
SDG
SDP
SES
SEW
SIN
SNL
SPCBC
SSH
SSI
SSZ
SVS
T5K
UKHRP
UV1
WH7
WOW
WUQ
XPP
Z5R
ZGI
ZXP
~G-
~HD
3V.
AACTN
AFCTW
AFKWA
AJOXV
ALIPV
AMFUW
RIG
AAIAV
ABLVK
ABYKQ
AESVU
AJBFU
LCYCR
QYZTP
AAYXX
CITATION
PUEGO
AGCQF
AGRNS
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T2
7T5
7U9
7XB
8FK
AFFHD
C1K
H94
K9.
M7N
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
ID FETCH-LOGICAL-c564t-bc1bc1b5c0b020286556231971eaf936c7c8fdbca834eef264436cf0b46093653
IEDL.DBID BENPR
ISSN 0264-410X
1873-2518
IngestDate Thu Oct 02 11:49:54 EDT 2025
Tue Oct 07 08:17:13 EDT 2025
Tue Oct 28 03:39:29 EDT 2025
Thu Apr 03 07:00:01 EDT 2025
Mon Jul 21 09:17:25 EDT 2025
Thu Apr 24 23:00:52 EDT 2025
Wed Oct 01 04:17:29 EDT 2025
Fri Feb 23 02:28:41 EST 2024
Sun Feb 23 10:19:56 EST 2025
Tue Oct 14 19:35:58 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 43
Keywords MHC polymorphism
OMP
Population coverage
T-cell epitope
MenB
IEDB
MHC
Neisseria meningitidis
Vaccine
HLA
Neisseria meningitidis Serogroup B
major histocompatibility complex
outer membrane protein
human leucocyte antigen
Immune Epitope Database
HLA-System
CD4 T lymphocyte
Antigenic determinant
Major histocompatibility system
Neisseriaceae
Protein
T-Lymphocyte
Bacteria
Micrococcales
Polymorphism
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
Copyright © 2010 Elsevier Ltd. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c564t-bc1bc1b5c0b020286556231971eaf936c7c8fdbca834eef264436cf0b46093653
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
PMID 20716448
PQID 1497226668
PQPubID 105530
PageCount 6
ParticipantIDs proquest_miscellaneous_757463781
proquest_miscellaneous_1500772093
proquest_journals_1497226668
pubmed_primary_20716448
pascalfrancis_primary_23341470
crossref_primary_10_1016_j_vaccine_2010_08_005
crossref_citationtrail_10_1016_j_vaccine_2010_08_005
elsevier_sciencedirect_doi_10_1016_j_vaccine_2010_08_005
elsevier_clinicalkeyesjournals_1_s2_0_S0264410X1001114X
elsevier_clinicalkey_doi_10_1016_j_vaccine_2010_08_005
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-10-08
PublicationDateYYYYMMDD 2010-10-08
PublicationDate_xml – month: 10
  year: 2010
  text: 2010-10-08
  day: 08
PublicationDecade 2010
PublicationPlace Kidlington
PublicationPlace_xml – name: Kidlington
– name: Netherlands
PublicationTitle Vaccine
PublicationTitleAlternate Vaccine
PublicationYear 2010
Publisher Elsevier Ltd
Elsevier
Elsevier Limited
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
– name: Elsevier Limited
References Ait-Tahar, Wooldridge, Turner, Atta, Todd, Ala’Aldeen (bib0095) 2000; 37
The immune epitope database 2.0. Nucleic Acids Res 2010;38(Database issue):D854–62.
Gupta, Singh, Srivastava, Gupta, Akhoon (bib0185) 2009; 28
Zollinger, Mandrell, Griffiss, Altieri, Berman (bib0040) 1979; 63
Bui, Sidney, Dinh, Southwood, Newman, Sette (bib0150) 2006; 7
Agrawal, Srivastava, Borkar, Chaudhuri (bib0155) 2008; 72
Pace, Pollard (bib0010) 2007; 92
Lifely, Rogers, Esdaile, Payne, John (bib0135) 1992; 10
Davies, Flower (bib0245) 2007; 12
Brusic, August, Petrovsky (bib0180) 2005; 4
Wiwanitkit (bib0270) 2007; 25
A database of MHC/TAP binding peptides and T-cell epitopes. BMC Res Notes 2009;2:61.
Gregory, Lesinski, Julie (bib0105) 2001; 47
Brusic, August (bib0210) 2004; 5
Rammensee, Bachmann, Emmerich, Bachor, Stevanovic (bib0170) 1999; 50
De Groot, McMurry, Marcon, Franco, Rivera, Kutzler (bib0255) 2005; 23
Poolman, Berthet (bib0065) 2001; 20
Kvalsvig, Unsworth (bib0020) 2003; 56
Azizi, Diaz-Mitoma (bib0225) 2008; 13
Rosenstein, Perkins, Stephens, Lefkowitz, Cartter, Danila (bib0005) 1999; 180
Saukkonen, Abdillahi, Poolman, Leinonen (bib0070) 1987; 3
Tsirpouchtsidis, Hurwitz, Brinkmann, Meyer, Haas (bib0100) 2002; 70
Lin, Zhang, Tongchusak, Reinherz, Brusic (bib0280) 2008; 9
Chaitra, Hariharaputran, Chandra, Shaila, Nayak (bib0260) 2005; 23
Amir-Kroll, Riveron, Sarmiento, Sierra, Acosta, Cohen (bib0130) 2006; 24
Stern, Wiley (bib0205) 1994; 2
Reche, Reinherz (bib0195) 2003; 331
Doytchinova, Flower (bib0275) 2007; 25
Parida, Shaila, Mukherjee, Chandra, Nayak (bib0265) 2007; 25
Doytchinova, Guan, Flower (bib0240) 2004; 34
Wyle, Artenstein, Brandt, Tramont, Kasper, Altieri (bib0035) 1972; 126
Flower (bib0235) 2003; 24
De Groot, Sbai, Aubin, McMurry, Martin (bib0230) 2002; 80
Howe, Dillon, Rogers, McCarter, Kelly, Gonzalez (bib0110) 2009; 131
Kizil, Todd, Atta, Borriello, Ait-Tahar, Ala’Aldeen (bib0090) 1999; 67
Rosenstein, Fischer, Tappero (bib0085) 2001; 15
Raziuddin, el-Awad, Mir (bib0115) 1991; 87
Esser, Marchese, Kierstead, Tussey, Wang, Chirmule (bib0190) 2003; 21
Vaughan, Skipp, O’Connor, Hudson, Vipond, Elmore (bib0120) 2006; 24
Bjune, Hoiby, Gronnesby, Arnesen, Fredriksen, Halstensen (bib0055) 1991; 338
De Groot (bib0175) 2006; 11
Finne, Bitter-Suermann, Goridis, Finne (bib0030) 1987; 138
Finne, Leinonen, Makela (bib0050) 1983; 322
Ovsyannikova, Jacobson, Poland (bib0215) 2004; 5
Verheul, Snippe, Poolman (bib0060) 1993; 57
Mesa, de León, Fernández (bib0125) 2006; 24
Rosenqvist, Hoiby, Wedege, Caugant, Froholm, McGuinness (bib0075) 1993; 15
Frasch (bib0015) 1989; 2
Sette, Sidney (bib0220) 1999; 50
Rosenqvist, Hoiby, Wedege, Kusecek, Achtman (bib0080) 1993; 167
Chabot, Goetghebeur, Grégoire (bib0250) 2004; 22
Idanpaan-Heikkila, Muttilainen, Wahlstrdm, Saarinen, Leinonen, Sarvas (bib0025) 1995; 13
Maenaka, Jones (bib0200) 2009; 9
Frasch (bib0045) 1989; 2
Nielsen, Lundegaard, Blicher, Peters, Sette (bib0140) 2008; 4
Raziuddin (10.1016/j.vaccine.2010.08.005_bib0115) 1991; 87
Rammensee (10.1016/j.vaccine.2010.08.005_bib0170) 1999; 50
Zollinger (10.1016/j.vaccine.2010.08.005_bib0040) 1979; 63
Poolman (10.1016/j.vaccine.2010.08.005_bib0065) 2001; 20
Tsirpouchtsidis (10.1016/j.vaccine.2010.08.005_bib0100) 2002; 70
Rosenstein (10.1016/j.vaccine.2010.08.005_bib0085) 2001; 15
Lifely (10.1016/j.vaccine.2010.08.005_bib0135) 1992; 10
Flower (10.1016/j.vaccine.2010.08.005_bib0235) 2003; 24
Lin (10.1016/j.vaccine.2010.08.005_bib0280) 2008; 9
Bjune (10.1016/j.vaccine.2010.08.005_bib0055) 1991; 338
Brusic (10.1016/j.vaccine.2010.08.005_bib0180) 2005; 4
Frasch (10.1016/j.vaccine.2010.08.005_bib0015) 1989; 2
De Groot (10.1016/j.vaccine.2010.08.005_bib0175) 2006; 11
Kvalsvig (10.1016/j.vaccine.2010.08.005_bib0020) 2003; 56
Frasch (10.1016/j.vaccine.2010.08.005_bib0045) 1989; 2
Amir-Kroll (10.1016/j.vaccine.2010.08.005_bib0130) 2006; 24
Stern (10.1016/j.vaccine.2010.08.005_bib0205) 1994; 2
Finne (10.1016/j.vaccine.2010.08.005_bib0030) 1987; 138
Idanpaan-Heikkila (10.1016/j.vaccine.2010.08.005_bib0025) 1995; 13
De Groot (10.1016/j.vaccine.2010.08.005_bib0255) 2005; 23
Azizi (10.1016/j.vaccine.2010.08.005_bib0225) 2008; 13
Rosenstein (10.1016/j.vaccine.2010.08.005_bib0005) 1999; 180
Doytchinova (10.1016/j.vaccine.2010.08.005_bib0240) 2004; 34
Rosenqvist (10.1016/j.vaccine.2010.08.005_bib0075) 1993; 15
Gregory (10.1016/j.vaccine.2010.08.005_bib0105) 2001; 47
Doytchinova (10.1016/j.vaccine.2010.08.005_bib0275) 2007; 25
10.1016/j.vaccine.2010.08.005_bib0160
Brusic (10.1016/j.vaccine.2010.08.005_bib0210) 2004; 5
Wiwanitkit (10.1016/j.vaccine.2010.08.005_bib0270) 2007; 25
Wyle (10.1016/j.vaccine.2010.08.005_bib0035) 1972; 126
Chabot (10.1016/j.vaccine.2010.08.005_bib0250) 2004; 22
Saukkonen (10.1016/j.vaccine.2010.08.005_bib0070) 1987; 3
Rosenqvist (10.1016/j.vaccine.2010.08.005_bib0080) 1993; 167
Sette (10.1016/j.vaccine.2010.08.005_bib0220) 1999; 50
Chaitra (10.1016/j.vaccine.2010.08.005_bib0260) 2005; 23
Mesa (10.1016/j.vaccine.2010.08.005_bib0125) 2006; 24
Maenaka (10.1016/j.vaccine.2010.08.005_bib0200) 2009; 9
Parida (10.1016/j.vaccine.2010.08.005_bib0265) 2007; 25
Reche (10.1016/j.vaccine.2010.08.005_bib0195) 2003; 331
Nielsen (10.1016/j.vaccine.2010.08.005_bib0140) 2008; 4
Ovsyannikova (10.1016/j.vaccine.2010.08.005_bib0215) 2004; 5
Verheul (10.1016/j.vaccine.2010.08.005_bib0060) 1993; 57
Finne (10.1016/j.vaccine.2010.08.005_bib0050) 1983; 322
De Groot (10.1016/j.vaccine.2010.08.005_bib0230) 2002; 80
Bui (10.1016/j.vaccine.2010.08.005_bib0150) 2006; 7
Howe (10.1016/j.vaccine.2010.08.005_bib0110) 2009; 131
Kizil (10.1016/j.vaccine.2010.08.005_bib0090) 1999; 67
Vaughan (10.1016/j.vaccine.2010.08.005_bib0120) 2006; 24
Esser (10.1016/j.vaccine.2010.08.005_bib0190) 2003; 21
Davies (10.1016/j.vaccine.2010.08.005_bib0245) 2007; 12
Pace (10.1016/j.vaccine.2010.08.005_bib0010) 2007; 92
Agrawal (10.1016/j.vaccine.2010.08.005_bib0155) 2008; 72
10.1016/j.vaccine.2010.08.005_bib0165
Gupta (10.1016/j.vaccine.2010.08.005_bib0185) 2009; 28
Ait-Tahar (10.1016/j.vaccine.2010.08.005_bib0095) 2000; 37
References_xml – volume: 20
  start-page: S24
  year: 2001
  end-page: S26
  ident: bib0065
  article-title: Alternative vaccine strategies to prevent serogroup B meningococcal diseases
  publication-title: Vaccine
– volume: 50
  start-page: 201
  year: 1999
  end-page: 212
  ident: bib0220
  article-title: Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism
  publication-title: Immunogenetics
– volume: 5
  start-page: 417
  year: 2004
  end-page: 427
  ident: bib0215
  article-title: Variation in vaccine response in normal populations
  publication-title: Pharmacogenomics
– volume: 24
  start-page: 2692
  year: 2006
  end-page: 2699
  ident: bib0125
  article-title: Very small size proteoliposomes derived from
  publication-title: Vaccine
– volume: 70
  start-page: 335
  year: 2002
  end-page: 344
  ident: bib0100
  article-title: Neisserial Immunoglobulin A1 protease induces specific T-cell responses in humans
  publication-title: Infect Immun
– volume: 131
  start-page: 317
  year: 2009
  end-page: 332
  ident: bib0110
  article-title: Evidence for dendritic cell-dependent CD4+ T helper-1 type responses to commensal bacteria in normal human intestinal laminapropria
  publication-title: Clin Immunol
– volume: 22
  start-page: 1992
  year: 2004
  end-page: 2005
  ident: bib0250
  article-title: The societal value of universal childhood vaccination
  publication-title: Vaccine
– volume: 5
  start-page: 597
  year: 2004
  end-page: 600
  ident: bib0210
  article-title: The changing field of vaccine development in the genomics era
  publication-title: Pharmacogenomics
– volume: 13
  start-page: 1501
  year: 1995
  end-page: 1508
  ident: bib0025
  article-title: The antibody response to a prototype liposome vaccine containing Neisseria meningitides outer membrane protein P1 produced in
  publication-title: Vaccine
– volume: 25
  start-page: 7530
  year: 2007
  end-page: 7539
  ident: bib0265
  article-title: Computational analysis of proteome of H5N1 avian influenza virus to define T cell epitopes with vaccine potential
  publication-title: Vaccine
– volume: 57
  start-page: 34
  year: 1993
  end-page: 49
  ident: bib0060
  article-title: Meningococcal lipopolysaccharides: virulence factor and potential vaccine component
  publication-title: Microbiol Rev
– volume: 37
  start-page: 1094
  year: 2000
  end-page: 1105
  ident: bib0095
  article-title: Auto-transporter A (AutA) protein of
  publication-title: Mol Microbiol
– volume: 25
  start-page: 2768
  year: 2007
  end-page: 2770
  ident: bib0270
  article-title: Predicted epitopes of Lig A of
  publication-title: Vaccine
– volume: 25
  start-page: 856
  year: 2007
  end-page: 866
  ident: bib0275
  article-title: Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties
  publication-title: Vaccine
– volume: 67
  start-page: 3533
  year: 1999
  end-page: 3541
  ident: bib0090
  article-title: Identification and characterization of TspA, a major CD4+ T-cell- and B-cell-stimulating Neisseria-specific antigen
  publication-title: Infect Immun
– volume: 11
  start-page: 203
  year: 2006
  end-page: 209
  ident: bib0175
  article-title: Immunomics: discovering new targets for vaccines and therapeutics
  publication-title: Drug Discov Today
– volume: 9
  start-page: 745
  year: 2009
  end-page: 753
  ident: bib0200
  article-title: MHC superfamily structure and the immune system
  publication-title: Curr Opin Struct Biol
– volume: 12
  start-page: 389
  year: 2007
  end-page: 395
  ident: bib0245
  article-title: Harnessing bioinformatics to discover new vaccines
  publication-title: Drug Discov Today
– volume: 28
  start-page: 120
  year: 2009
  end-page: 131
  ident: bib0185
  article-title: In silico DNA vaccine designing against human papillomavirus (HPV) causing cervical cancer
  publication-title: Vaccine
– volume: 2
  start-page: S134
  year: 1989
  end-page: S138
  ident: bib0015
  article-title: Vaccines for prevention of meningococcal disease
  publication-title: Clin Microbiol Rev
– volume: 34
  start-page: 444
  year: 2004
  end-page: 453
  ident: bib0240
  article-title: Quantitative structure-activity relationships and the prediction of MHC supermotifs
  publication-title: Methods
– volume: 80
  start-page: 255
  year: 2002
  end-page: 269
  ident: bib0230
  article-title: Immuno-informatics: mining genomes for vaccine components
  publication-title: Immunol Cell Biol
– volume: 180
  start-page: 1894
  year: 1999
  end-page: 1901
  ident: bib0005
  article-title: The changing epidemiology of meningococcal disease in the United States, 1992–1996
  publication-title: J Infect Dis
– volume: 15
  start-page: 155
  year: 2001
  end-page: 169
  ident: bib0085
  article-title: Meningococcal vaccines
  publication-title: Infect Dis Clin N Am
– volume: 4
  start-page: e1000107
  year: 2008
  ident: bib0140
  article-title: Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan
  publication-title: PLoS Comput Biol
– volume: 87
  start-page: 1115
  year: 1991
  end-page: 1120
  ident: bib0115
  article-title: Bacterial meningitis: T cell activation and immunoregulatory CD4+ T cell subset alteration
  publication-title: J Allergy Clin Immunol
– reference: The immune epitope database 2.0. Nucleic Acids Res 2010;38(Database issue):D854–62.
– volume: 24
  start-page: 667
  year: 2003
  end-page: 674
  ident: bib0235
  article-title: Towards in silico prediction of immunogenic epitopes
  publication-title: Trends Immunol
– volume: 7
  start-page: 153
  year: 2006
  ident: bib0150
  article-title: Predicting population coverage of T-cell epitope-based diagnostics and vaccines
  publication-title: BMC Bioinform
– volume: 322
  start-page: 355
  year: 1983
  end-page: 357
  ident: bib0050
  article-title: Antigenic similarities between brain components and bacteria causing meningitidis. Implications for vaccine development and pathogenesis
  publication-title: Lancet
– volume: 21
  start-page: 419
  year: 2003
  end-page: 430
  ident: bib0190
  article-title: Memory T cells and vaccines
  publication-title: Vaccine
– volume: 126
  start-page: 51
  year: 1972
  end-page: 52
  ident: bib0035
  article-title: Immunologic response of man to group B meningococcal polysaccharide vaccines
  publication-title: J Infect Dis
– volume: 10
  start-page: 159
  year: 1992
  end-page: 163
  ident: bib0135
  article-title: Murine cross-reactive T-cell epitopes of
  publication-title: Vaccine
– volume: 138
  start-page: 4402
  year: 1987
  end-page: 4407
  ident: bib0030
  article-title: An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues
  publication-title: J Immunol
– volume: 47
  start-page: 135
  year: 2001
  end-page: 149
  ident: bib0105
  article-title: Novel vaccine strategies to T-independent antigens
  publication-title: J Microb Methods
– volume: 13
  start-page: 776
  year: 2008
  end-page: 786
  ident: bib0225
  article-title: Viral peptide immunogens: current challenges and opportunities
  publication-title: J Peptide Sci
– volume: 15
  start-page: 197
  year: 1993
  end-page: 205
  ident: bib0075
  article-title: A new variant of serosubtype P1.16 in
  publication-title: Microb Pathog
– volume: 167
  start-page: 1065
  year: 1993
  end-page: 1073
  ident: bib0080
  article-title: The 5C protein of
  publication-title: J Infect Dis
– volume: 63
  start-page: 836
  year: 1979
  end-page: 848
  ident: bib0040
  article-title: Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man
  publication-title: J Clin Invest
– volume: 24
  start-page: 5277
  year: 2006
  end-page: 5293
  ident: bib0120
  article-title: Proteomic analysis of
  publication-title: Vaccine
– volume: 338
  start-page: 1093
  year: 1991
  end-page: 1096
  ident: bib0055
  article-title: Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway
  publication-title: Lancet
– volume: 50
  start-page: 213
  year: 1999
  end-page: 219
  ident: bib0170
  article-title: SYFPEITHI: database for MHC ligands and peptide motifs
  publication-title: Immunogenetics
– volume: 2
  start-page: 245
  year: 1994
  end-page: 251
  ident: bib0205
  article-title: Antigen peptide binding by class I and class II histocompatibility proteins
  publication-title: Structure
– volume: 24
  start-page: 6555
  year: 2006
  end-page: 6563
  ident: bib0130
  article-title: A conjugate vaccine composed of a heat shock protein 60 T-cell epitope peptide (p458) and
  publication-title: Vaccine
– volume: 72
  start-page: 120
  year: 2008
  end-page: 130
  ident: bib0155
  article-title: Genetic affinities of north and northeastern populations of India: inference from HLA-based study
  publication-title: Tissue Antigens
– volume: 92
  start-page: 909
  year: 2007
  end-page: 915
  ident: bib0010
  article-title: Meningococcal A, C, Y and W-135 polysaccharide–protein conjugate vaccines
  publication-title: Arch Dis Child
– volume: 2
  start-page: 5134
  year: 1989
  end-page: 5138
  ident: bib0045
  article-title: Vaccines for prevention of meningococcal disease
  publication-title: Clin Microbial Rev
– volume: 23
  start-page: 2121
  year: 2005
  end-page: 2131
  ident: bib0255
  article-title: Developing an epitope-driven tuberculosis (TB) vaccine
  publication-title: Vaccine
– volume: 4
  start-page: 407
  year: 2005
  end-page: 417
  ident: bib0180
  article-title: Information technologies for vaccine research
  publication-title: Expert Rev Vaccines
– volume: 56
  start-page: 417
  year: 2003
  end-page: 422
  ident: bib0020
  article-title: The immunopathogenesis of meningococcal disease
  publication-title: J Clin Pathol
– volume: 3
  start-page: 261
  year: 1987
  end-page: 267
  ident: bib0070
  article-title: Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of
  publication-title: Microb Pathog
– volume: 23
  start-page: 1265
  year: 2005
  end-page: 1272
  ident: bib0260
  article-title: Defining putative T cell epitopes from PE and PPE families of proteins of
  publication-title: Vaccine
– volume: 9
  start-page: S22
  year: 2008
  ident: bib0280
  article-title: Evaluation of MHC-II peptide binding prediction servers
  publication-title: BMC Bioinform
– volume: 331
  start-page: 623
  year: 2003
  end-page: 641
  ident: bib0195
  article-title: Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms
  publication-title: J Mol Biol
– reference: A database of MHC/TAP binding peptides and T-cell epitopes. BMC Res Notes 2009;2:61.
– volume: 9
  start-page: 745
  year: 2009
  ident: 10.1016/j.vaccine.2010.08.005_bib0200
  article-title: MHC superfamily structure and the immune system
  publication-title: Curr Opin Struct Biol
  doi: 10.1016/S0959-440X(99)00039-1
– volume: 11
  start-page: 203
  year: 2006
  ident: 10.1016/j.vaccine.2010.08.005_bib0175
  article-title: Immunomics: discovering new targets for vaccines and therapeutics
  publication-title: Drug Discov Today
  doi: 10.1016/S1359-6446(05)03720-7
– volume: 2
  start-page: 5134
  year: 1989
  ident: 10.1016/j.vaccine.2010.08.005_bib0045
  article-title: Vaccines for prevention of meningococcal disease
  publication-title: Clin Microbial Rev
  doi: 10.1128/CMR.2.Suppl.S134
– volume: 72
  start-page: 120
  issue: 2
  year: 2008
  ident: 10.1016/j.vaccine.2010.08.005_bib0155
  article-title: Genetic affinities of north and northeastern populations of India: inference from HLA-based study
  publication-title: Tissue Antigens
  doi: 10.1111/j.1399-0039.2008.01083.x
– volume: 25
  start-page: 856
  year: 2007
  ident: 10.1016/j.vaccine.2010.08.005_bib0275
  article-title: Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2006.09.032
– volume: 87
  start-page: 1115
  year: 1991
  ident: 10.1016/j.vaccine.2010.08.005_bib0115
  article-title: Bacterial meningitis: T cell activation and immunoregulatory CD4+ T cell subset alteration
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/0091-6749(91)92157-V
– volume: 56
  start-page: 417
  year: 2003
  ident: 10.1016/j.vaccine.2010.08.005_bib0020
  article-title: The immunopathogenesis of meningococcal disease
  publication-title: J Clin Pathol
  doi: 10.1136/jcp.56.6.417
– volume: 57
  start-page: 34
  year: 1993
  ident: 10.1016/j.vaccine.2010.08.005_bib0060
  article-title: Meningococcal lipopolysaccharides: virulence factor and potential vaccine component
  publication-title: Microbiol Rev
  doi: 10.1128/MMBR.57.1.34-49.1993
– volume: 5
  start-page: 417
  year: 2004
  ident: 10.1016/j.vaccine.2010.08.005_bib0215
  article-title: Variation in vaccine response in normal populations
  publication-title: Pharmacogenomics
  doi: 10.1517/14622416.5.4.417
– volume: 331
  start-page: 623
  year: 2003
  ident: 10.1016/j.vaccine.2010.08.005_bib0195
  article-title: Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms
  publication-title: J Mol Biol
  doi: 10.1016/S0022-2836(03)00750-2
– volume: 13
  start-page: 1501
  year: 1995
  ident: 10.1016/j.vaccine.2010.08.005_bib0025
  article-title: The antibody response to a prototype liposome vaccine containing Neisseria meningitides outer membrane protein P1 produced in Bacillus subtilis
  publication-title: Vaccine
  doi: 10.1016/0264-410X(95)00101-6
– volume: 34
  start-page: 444
  year: 2004
  ident: 10.1016/j.vaccine.2010.08.005_bib0240
  article-title: Quantitative structure-activity relationships and the prediction of MHC supermotifs
  publication-title: Methods
  doi: 10.1016/j.ymeth.2004.06.007
– volume: 131
  start-page: 317
  year: 2009
  ident: 10.1016/j.vaccine.2010.08.005_bib0110
  article-title: Evidence for dendritic cell-dependent CD4+ T helper-1 type responses to commensal bacteria in normal human intestinal laminapropria
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2008.12.003
– volume: 10
  start-page: 159
  year: 1992
  ident: 10.1016/j.vaccine.2010.08.005_bib0135
  article-title: Murine cross-reactive T-cell epitopes of Neisseria meningitidis outer membrane proteins
  publication-title: Vaccine
  doi: 10.1016/0264-410X(92)90005-5
– volume: 23
  start-page: 2121
  year: 2005
  ident: 10.1016/j.vaccine.2010.08.005_bib0255
  article-title: Developing an epitope-driven tuberculosis (TB) vaccine
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2005.01.059
– volume: 2
  start-page: 245
  year: 1994
  ident: 10.1016/j.vaccine.2010.08.005_bib0205
  article-title: Antigen peptide binding by class I and class II histocompatibility proteins
  publication-title: Structure
  doi: 10.1016/S0969-2126(00)00026-5
– volume: 13
  start-page: 776
  year: 2008
  ident: 10.1016/j.vaccine.2010.08.005_bib0225
  article-title: Viral peptide immunogens: current challenges and opportunities
  publication-title: J Peptide Sci
  doi: 10.1002/psc.896
– volume: 4
  start-page: 407
  year: 2005
  ident: 10.1016/j.vaccine.2010.08.005_bib0180
  article-title: Information technologies for vaccine research
  publication-title: Expert Rev Vaccines
  doi: 10.1586/14760584.4.3.407
– volume: 5
  start-page: 597
  year: 2004
  ident: 10.1016/j.vaccine.2010.08.005_bib0210
  article-title: The changing field of vaccine development in the genomics era
  publication-title: Pharmacogenomics
  doi: 10.1517/14622416.5.6.597
– volume: 50
  start-page: 201
  year: 1999
  ident: 10.1016/j.vaccine.2010.08.005_bib0220
  article-title: Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism
  publication-title: Immunogenetics
  doi: 10.1007/s002510050594
– volume: 3
  start-page: 261
  year: 1987
  ident: 10.1016/j.vaccine.2010.08.005_bib0070
  article-title: Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development
  publication-title: Microb Pathog
  doi: 10.1016/0882-4010(87)90059-3
– volume: 37
  start-page: 1094
  year: 2000
  ident: 10.1016/j.vaccine.2010.08.005_bib0095
  article-title: Auto-transporter A (AutA) protein of Neisseria meningitidis: a potent CD4+ T-cell and B-cell stimulating antigen detected by expression cloning
  publication-title: Mol Microbiol
  doi: 10.1046/j.1365-2958.2000.02061.x
– volume: 47
  start-page: 135
  year: 2001
  ident: 10.1016/j.vaccine.2010.08.005_bib0105
  article-title: Novel vaccine strategies to T-independent antigens
  publication-title: J Microb Methods
  doi: 10.1016/S0167-7012(01)00290-1
– volume: 24
  start-page: 5277
  year: 2006
  ident: 10.1016/j.vaccine.2010.08.005_bib0120
  article-title: Proteomic analysis of Neisseria lactamica and Neisseria meningitidis outer membrane vesicle vaccine antigens
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2006.03.013
– volume: 63
  start-page: 836
  year: 1979
  ident: 10.1016/j.vaccine.2010.08.005_bib0040
  article-title: Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man
  publication-title: J Clin Invest
  doi: 10.1172/JCI109383
– volume: 20
  start-page: S24
  year: 2001
  ident: 10.1016/j.vaccine.2010.08.005_bib0065
  article-title: Alternative vaccine strategies to prevent serogroup B meningococcal diseases
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(01)00283-3
– volume: 338
  start-page: 1093
  year: 1991
  ident: 10.1016/j.vaccine.2010.08.005_bib0055
  article-title: Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway
  publication-title: Lancet
  doi: 10.1016/0140-6736(91)91961-S
– volume: 4
  start-page: e1000107
  issue: 7
  year: 2008
  ident: 10.1016/j.vaccine.2010.08.005_bib0140
  article-title: Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan
  publication-title: PLoS Comput Biol
  doi: 10.1371/journal.pcbi.1000107
– ident: 10.1016/j.vaccine.2010.08.005_bib0165
  doi: 10.1093/nar/gkp1004
– volume: 24
  start-page: 667
  year: 2003
  ident: 10.1016/j.vaccine.2010.08.005_bib0235
  article-title: Towards in silico prediction of immunogenic epitopes
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2003.10.006
– volume: 22
  start-page: 1992
  year: 2004
  ident: 10.1016/j.vaccine.2010.08.005_bib0250
  article-title: The societal value of universal childhood vaccination
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2003.10.027
– volume: 167
  start-page: 1065
  year: 1993
  ident: 10.1016/j.vaccine.2010.08.005_bib0080
  article-title: The 5C protein of Neisseria meningitidis is highly immunogenic in humans and induces bactericidal antibodies
  publication-title: J Infect Dis
  doi: 10.1093/infdis/167.5.1065
– volume: 92
  start-page: 909
  year: 2007
  ident: 10.1016/j.vaccine.2010.08.005_bib0010
  article-title: Meningococcal A, C, Y and W-135 polysaccharide–protein conjugate vaccines
  publication-title: Arch Dis Child
  doi: 10.1136/adc.2006.111500
– volume: 15
  start-page: 197
  year: 1993
  ident: 10.1016/j.vaccine.2010.08.005_bib0075
  article-title: A new variant of serosubtype P1.16 in Neisseria meningitidis from Norway associated with increased resistance to bactericidal antibodies induced by a serogroup B outer membrane protein vaccine
  publication-title: Microb Pathog
  doi: 10.1006/mpat.1993.1070
– volume: 25
  start-page: 2768
  year: 2007
  ident: 10.1016/j.vaccine.2010.08.005_bib0270
  article-title: Predicted epitopes of Lig A of Leptospira interrogans by bioinformatics method: a clue further vaccine development
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2006.12.023
– volume: 23
  start-page: 1265
  year: 2005
  ident: 10.1016/j.vaccine.2010.08.005_bib0260
  article-title: Defining putative T cell epitopes from PE and PPE families of proteins of Mycobacterium tuberculosis with vaccine potential
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2004.08.046
– volume: 50
  start-page: 213
  year: 1999
  ident: 10.1016/j.vaccine.2010.08.005_bib0170
  article-title: SYFPEITHI: database for MHC ligands and peptide motifs
  publication-title: Immunogenetics
  doi: 10.1007/s002510050595
– volume: 180
  start-page: 1894
  year: 1999
  ident: 10.1016/j.vaccine.2010.08.005_bib0005
  article-title: The changing epidemiology of meningococcal disease in the United States, 1992–1996
  publication-title: J Infect Dis
  doi: 10.1086/315158
– volume: 67
  start-page: 3533
  year: 1999
  ident: 10.1016/j.vaccine.2010.08.005_bib0090
  article-title: Identification and characterization of TspA, a major CD4+ T-cell- and B-cell-stimulating Neisseria-specific antigen
  publication-title: Infect Immun
  doi: 10.1128/IAI.67.7.3533-3541.1999
– volume: 138
  start-page: 4402
  year: 1987
  ident: 10.1016/j.vaccine.2010.08.005_bib0030
  article-title: An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues
  publication-title: J Immunol
  doi: 10.4049/jimmunol.138.12.4402
– volume: 80
  start-page: 255
  year: 2002
  ident: 10.1016/j.vaccine.2010.08.005_bib0230
  article-title: Immuno-informatics: mining genomes for vaccine components
  publication-title: Immunol Cell Biol
  doi: 10.1046/j.1440-1711.2002.01092.x
– volume: 126
  start-page: 51
  year: 1972
  ident: 10.1016/j.vaccine.2010.08.005_bib0035
  article-title: Immunologic response of man to group B meningococcal polysaccharide vaccines
  publication-title: J Infect Dis
  doi: 10.1093/infdis/126.5.514
– volume: 25
  start-page: 7530
  year: 2007
  ident: 10.1016/j.vaccine.2010.08.005_bib0265
  article-title: Computational analysis of proteome of H5N1 avian influenza virus to define T cell epitopes with vaccine potential
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2007.08.044
– volume: 9
  start-page: S22
  issue: Suppl. 12
  year: 2008
  ident: 10.1016/j.vaccine.2010.08.005_bib0280
  article-title: Evaluation of MHC-II peptide binding prediction servers
  publication-title: BMC Bioinform
  doi: 10.1186/1471-2105-9-S12-S22
– volume: 12
  start-page: 389
  year: 2007
  ident: 10.1016/j.vaccine.2010.08.005_bib0245
  article-title: Harnessing bioinformatics to discover new vaccines
  publication-title: Drug Discov Today
  doi: 10.1016/j.drudis.2007.03.010
– volume: 2
  start-page: S134
  issue: Suppl.
  year: 1989
  ident: 10.1016/j.vaccine.2010.08.005_bib0015
  article-title: Vaccines for prevention of meningococcal disease
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.2.Suppl.S134
– volume: 15
  start-page: 155
  year: 2001
  ident: 10.1016/j.vaccine.2010.08.005_bib0085
  article-title: Meningococcal vaccines
  publication-title: Infect Dis Clin N Am
  doi: 10.1016/S0891-5520(05)70273-7
– volume: 24
  start-page: 6555
  year: 2006
  ident: 10.1016/j.vaccine.2010.08.005_bib0130
  article-title: A conjugate vaccine composed of a heat shock protein 60 T-cell epitope peptide (p458) and Neisseria meningitidis type B capsular polysaccharide
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2006.06.019
– volume: 21
  start-page: 419
  year: 2003
  ident: 10.1016/j.vaccine.2010.08.005_bib0190
  article-title: Memory T cells and vaccines
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(02)00407-3
– volume: 7
  start-page: 153
  year: 2006
  ident: 10.1016/j.vaccine.2010.08.005_bib0150
  article-title: Predicting population coverage of T-cell epitope-based diagnostics and vaccines
  publication-title: BMC Bioinform
  doi: 10.1186/1471-2105-7-153
– volume: 24
  start-page: 2692
  year: 2006
  ident: 10.1016/j.vaccine.2010.08.005_bib0125
  article-title: Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for generation of CTL responses to peptide and protein antigens
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2005.08.111
– volume: 28
  start-page: 120
  year: 2009
  ident: 10.1016/j.vaccine.2010.08.005_bib0185
  article-title: In silico DNA vaccine designing against human papillomavirus (HPV) causing cervical cancer
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.09.095
– ident: 10.1016/j.vaccine.2010.08.005_bib0160
  doi: 10.1186/1756-0500-2-61
– volume: 322
  start-page: 355
  year: 1983
  ident: 10.1016/j.vaccine.2010.08.005_bib0050
  article-title: Antigenic similarities between brain components and bacteria causing meningitidis. Implications for vaccine development and pathogenesis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(83)90340-9
– volume: 70
  start-page: 335
  year: 2002
  ident: 10.1016/j.vaccine.2010.08.005_bib0100
  article-title: Neisserial Immunoglobulin A1 protease induces specific T-cell responses in humans
  publication-title: Infect Immun
  doi: 10.1128/IAI.70.1.335-344.2002
SSID ssj0005319
Score 2.1393943
Snippet Neisseria meningitidis, an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries....
Abstract Neisseria meningitidis , an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing...
, an exclusive human pathogen, is a major cause of mortality due to meningococcal meningitis and sepsis in many developing countries. Three meningococcal...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 7092
SubjectTerms Algorithms
Allergy and Immunology
Antigens, Bacterial - immunology
Applied microbiology
Bacterial Proteins - immunology
Bacteriology
Biological and medical sciences
Carrier Proteins - immunology
Computational Biology
Databases, Protein
Developing countries
Epitopes, T-Lymphocyte - immunology
Fundamental and applied biological sciences. Psychology
Genomes
HLA-DR Antigens - immunology
Humans
LDCs
Lymphocytes
Meningitis
MHC polymorphism
Microbiology
Miscellaneous
Neisseria meningitidis
Neisseria meningitidis, Serogroup B - immunology
Neural networks
Neural Networks (Computer)
Peptides
Population
Population coverage
Proteins
Serine Endopeptidases - immunology
Servers
T-cell epitope
Vaccine
Vaccines
Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)
SummonAdditionalLinks – databaseName: Elsevier SD Freedom Collection Journals [SCFCJ]
  dbid: AIKHN
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELdGJxASQlD-BcZ0SGgvLGv-2E76WApTB6yaRIf6ZiWOI2UqabS0SHvjQ_Ah-Fx8Es6O02iCagipT44vcezz3c_N7-4Iec25kknCmBuoUOkSZtyNeRbpo0ooZR7SgOrg5NMpn5zTD3M23yHjNhZG0yqt7W9surHWtmVgZ3NQFcXgs2d8uTf3Tb10Or9FdtH_xHGP7I5OPk6mHdMjNPU9dH9XC3SBPIOLo2-J1F-wLclLEyvZNhd1r0pqnLi8qXixHZIa13T8gNy3mBJGzbAfkh1V9sntpsrkVZ_cObXfz_vk4KzJVH11CLMu8Ko-hAM463JYo0z_i6bJmFhdaMUfkZ8nJdTFApUHxu_oG5i5-n9_UBWahUpBdal76pWGpMxg8mkEmc7La0tqYWOTAAUQKAMCT6iWK01WwrGbdBFFWcMyh6kyHIEiga-qqadU4G0ArdrSxKDA21_ff4xALtbK3MnOLWQd_-kxOT9-PxtPXFvqwZWM05WbSl__mPRSxK8mWhZxmT-MfJXkw5DLSMZ5lsokDqlSuV55bMy9lHIPL7PwCemVy1I9I-CnnA0zhCY5w6NnkKeBlye5SlSsshjxsENou7pC2jzouhzHQrSEtwthBy60UghdptNjDjnaiFVNIpCbBHirOqKNckW7LNBV3SQY_U1Q1da61MIXdSA88ccOcEi8kby2if7lofvXtHvzjkGIOIdGnkP2WnUX3UBwcyN-5zx2yKvNZTRQWvuSUi3X2IfplFEBLpNDYEufiEWUh1HsO-Rps5O653v6RE_j5___bi_IXcP5MMzNPdJbXa7VS4SSq3TfmorfvkF0xg
  priority: 102
  providerName: Elsevier
Title In silico CD4+ T-cell epitope prediction and HLA distribution analysis for the potential proteins of Neisseria meningitidis Serogroup B—A clue for vaccine development
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0264410X1001114X
https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X1001114X
https://dx.doi.org/10.1016/j.vaccine.2010.08.005
https://www.ncbi.nlm.nih.gov/pubmed/20716448
https://www.proquest.com/docview/1497226668
https://www.proquest.com/docview/1500772093
https://www.proquest.com/docview/757463781
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals [SCFCJ]
  customDbUrl:
  eissn: 1873-2518
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005319
  issn: 0264-410X
  databaseCode: AIKHN
  dateStart: 20091030
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: Science Direct
  customDbUrl:
  eissn: 1873-2518
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005319
  issn: 0264-410X
  databaseCode: .~1
  dateStart: 19950101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVESC
  databaseName: ScienceDirect
  customDbUrl:
  eissn: 1873-2518
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005319
  issn: 0264-410X
  databaseCode: ACRLP
  dateStart: 20091030
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
– providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1873-2518
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0005319
  issn: 0264-410X
  databaseCode: AKRWK
  dateStart: 19831201
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1873-2518
  dateEnd: 20250901
  omitProxy: true
  ssIdentifier: ssj0005319
  issn: 0264-410X
  databaseCode: BENPR
  dateStart: 20020101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Health & Medical
  customDbUrl:
  eissn: 1873-2518
  dateEnd: 20250901
  omitProxy: true
  ssIdentifier: ssj0005319
  issn: 0264-410X
  databaseCode: 7X7
  dateStart: 20020101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Public Health Database
  customDbUrl:
  eissn: 1873-2518
  dateEnd: 20250901
  omitProxy: true
  ssIdentifier: ssj0005319
  issn: 0264-410X
  databaseCode: 8C1
  dateStart: 20020101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1tb9MwELa2ViAkhKC8BUZ1SGhfWLq82E76AaGubOqAVRVsU75ZieNInUoalhZpX_g7_E3OTtIIiTKkKIoSn-3Gl_Pj-u4eQt5wrmQcM2Z7yleawozbIU8DvVTxpcx86lEdnHw25ZML-jFi0Q6ZNrEw2q2ysYnGUKdLqf8jP0QkHyBU4Dx8X3y3NWuU3l1tKDTimlohfWdSjO2SrqczY3VI9-h4OvvSOn34huoDFx7Upq4TtTE9h1eDH1gLQrva30v7WLJts9X9Ii7xHWYV-cV2dGpmqZOH5EENL2FU6cMjsqPyHrlTEU7e9Mjds3orvUf2Z1XS6psDOG9jsMoD2IdZm84aZXqX2mPGhO1CI_6Y_DrNoZwvUI9g_IG-hXNbbwGAKtBCFAqKa11SDzrEeQqTzyNIdYreml0Lb1a5UAAxMyAGhWK50n5L2HeTOWKel7DMYKqMu8A8hm-qolaaYzWABm5pwlHgyLZHIBdrZSqqXy2krSfUE3Jxcnw-ntg16YMtGacrO5GuPph0EkSyJm4WEZo7DFwVZ0Ofy0CGWZrIOPSpUpnGc3gzcxLKHXzM_Kekky9z9ZyAm3A2TBGkZAwXoV6WeE4WZypWoUpDRMYWoc3gCllnRNfEHAvRuL5dibrjQuuE0ISdDrPIYCNWVClBbhPgjeaIJt4VLbTASes2weBvgqqs7UwpXFF6whFfHYNrnUhn1MIVbmSRcCNZQ6kKIv1Po_0_lHvzGz0fEQ8NHIvsNdou2o5sPk-LvN48RlOllS_O1XKNZZhOHuXhMFkEtpQJWEC5H4SuRZ5VH1LbvqPX9jR88e_2X5J7xsPD-Gnukc7qeq1eIXBcJX2yO_jp4jmIAjyHY7zujk4_Tab92k78Bqe5cnA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamTVwkhKDcAmMcJNgLy5aL46QPE-puallbVdChvplcHKlTScLSgvqL-Bf8No4dpxESZbxM6lPiE7v16fHn-DvnI-QNYyIOQ88zHeEKKWHGzIAlvtyquHGcutShMjl5MGTdC_ph4k02yK86F0bSKuuYqAJ1ksfyHfkBInkfoQJjwfvimylVo-Tpai2hEWppheRQlRjTiR3nYvkDt3DlYe8E5_ut45ydjo-7plYZMGOP0bkZxbb8eLEVIXRSiZoICey2b4swbbss9uMgTaI4DFwqRCoBBF5MrYgyC29L1QhcAraoiwPcJFtHp8PRx4Zk4ippEdzoUJPa1qTJITq43P-Oo0YoqfllktPprVsd7xVhiXOWVmIb69GwWhXPHpD7Gs5Cp_K_h2RDZC1yqxK4XLbI7YE-um-R3VFVJHu5B-Mm56vcg10YNeWz0ab1WTJ0VJow1OaPyM9eBuV0hn4Lxyf0HYxNeeQAosCIVAgormRL6WQQZgl0-x1IZElgreaFF6vaK4AYHRDzQpHPJU8Kx64qVUyzEvIUhkLRE6YhfBWVlNMUHwMYUHOV_gJHptmBeLYQ6kH6p4WkYV49Jhc3Mv1PyGaWZ-IZATtiXjtBUJR6uOl10six0jAVoQhEEiASNwitJ5fHugK7FAKZ8Zpqd8n1wLn0CS4FQi3PIPsrs6IqQXKdAas9h9f5tbgicFwkrzP0_2YoSh3XSm7z0uEW_2QpHG1NZAUv3FFPDBKsLDV0qyDZ_3S684dzr76j4yLCor5lkO3a23kzkFU4MMjr1W0MjdL5wkzkC2zjyWJVDk6TQWBNG9_zKXP9wDbI0-qP1PRvyXcJNHj-7_5fkTvd8aDP-73h-QtyV7FLFEd0m2zOrxbiJYLWebSjIwOQLzcdjH4DHSOqeg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3bbtQwELWqIiokhGC5BUoZJOgLTTcXx8k-IFRaVi1tV5Voq7yZxHGkrZYkNFtQv4h_4OuYcZKNkCjlpdI-JZ7Yu54dH8dn5jD2WgitkiQIbE_7miTMhB2JLKStiq9U7nOPU3Ly4UTsnvBPcRAvsV9dLgzRKruYaAJ1Vip6Rz5EJB8iVBAiGuYtLeJoZ_y--maTghSdtHZyGo2L7OvLH7h9q9_t7eBcv_G88cfj7V27VRiwVSD43E6VS59AOSnCJpOkiXDAHYWuTvKRL1SoojxLVRL5XOucwANezJ2UCwdvk2IEhv9boe-PiE4YxmFPL_GNqAhucbjNXSfus4eGZ5vfE0XH5i2zjNicwVXr4t0qqXG28kZm42ocbNbD8X12rwWysNV43gO2pIsBu91IW14O2Mphe2g_YOtHTXnsyw047rO96g1Yh6O-cDbaDE6Jm2MShKEzf8h-7hVQT2fosbC9w9_CsU2HDaArjEWVhuqcWpJ7QVJksHuwBRkVA251vPBiU3UFEJ0Dol2oyjkxpHDspkbFtKihzGGiDTFhmsBX3Yg4TfExgKG0NIkv8MG2t0DNLrR5UPvTQtZzrh6xkxuZ_MdsuSgL_ZSBm4pglCEcygPc7np56jl5kutERzqLEINbjHeTK1Vbe50kQGayI9mdyXbgknxCkjSoE1hsc2FWNcVHrjMQnefILrMW1wKJy-N1huHfDHXdRrRaurL2pCM_OwZBOzHV7sK9dGyxaGHZgrYGjP1Pp2t_OPfiO3o-YiseOhZb7bxd9gNZBAKLvVrcxqBIzpcUurzANgGVqfJwmiwGV7QJg5ALP4xciz1p_kh9_w69ReDRs3_3_5KtYAiSB3uT_efsjqGVGHLoKluen1_oF4hW5-maCQvAvtx0HPoNcq2oFA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+silico+CD4%2B+T-cell+epitope+prediction+and+HLA+distribution+analysis+for+the+potential+proteins+of+Neisseria+meningitidis+Serogroup+B--A+clue+for+vaccine+development&rft.jtitle=Vaccine&rft.au=Gupta%2C+Shishir+K&rft.au=Smita%2C+Suchi&rft.au=Sarangi%2C+Aditya+Narayan&rft.au=Srivastava%2C+Mugdha&rft.date=2010-10-08&rft.pub=Elsevier+Limited&rft.issn=0264-410X&rft.eissn=1873-2518&rft.volume=28&rft.issue=43&rft.spage=7092&rft_id=info:doi/10.1016%2Fj.vaccine.2010.08.005&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=3216315331
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0264410X%2FS0264410X10X00469%2Fcov150h.gif